Bayer and Zydus Cadila Form Pharmaceuticals Joint Venture in India

Bayer HealthCare and Zydus Cadila (Ahmedabad, India) signed an agreement in Mumbai today to form an equally owned marketing and sales joint venture, Bayer Zydus Pharma (Mumbai). The formation of Bayer Zydus Pharma is a "crucial element" in Bayer's strategy to build a stronger presence in the emerging markets, the company says. "With this step, we aim to signficantly accellerate our capabilities to better serve the fast growing Indian market," says Jörg Reinhardt, CEO of Bayer HealthCare. Both partners will bring into Bayer Zydus Pharma a...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers